Gallery Thumb 0
Gallery Thumb 1

Decreasing Impact & Increasing Sustainability: API manufacturing in modern drug development

Webinar Info: Recorded June 21, 2021

In this webinar we will share a general overview of the drug development process. As part of this overview, general API manufacturing principals will also be discussed, highlighting where manufacturing makes the most impact in successful drug development. Lastly, modern day environmental challenges will be presented, with key technologies that can be applied to reduce impact and increase sustainability. Raybow's Ryan Gil presents with Dirk Hütten hosting.

There will be a live Q&A following the presentation. As always the webinar will be recorded and available to registrants on-demand following the event.


Ryan Gil will present with Dirk Hütten hosting.
Ryan Gil

Ryan Gil

Senior Manager, Business DevelopmentRaybow Pharmaceutical

Ryan Gil has a MSc from the University of Aberdeen and has over 5 years of experience as an analytical chemist in biochemistry and toxicology. He joined Raybow in February of 2021 and enjoys hiking and skiing in the beautiful Bavarian Apls.

Dirk Hütten

Dirk Hütten

Senior Director Business DevelopmentRaybow Pharmaceutical

Dr. Dirk Hütten holds a PhD in Chemistry from the University of Cologne, Germany. He has more than 20 years of experience in global sales and marketing alongside the supply chain of pharmaceuticals and APIs including positions at GSK, Altana and PharmaZell. In 2019, he joined Raybow Pharmaceutical as Senior Director Business Development. In addition, Dirk is passionate about high performance sailing.

Registration Page

Sign Up